Lack of stimulatory activity of a Phytoestrogen-containing soy extract on the growth of breast cancer tumors in mice

Carcinogenesis

Volumn 27, Issue 7, 2006, Pages 1404-1409

  Gallo, Daniela ^a   Ferlini, Cristiano ^a   Fabrizi, Manuela ^a   Prislei, Silvia ^a   Scambia, Giovanni ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CYCLIN D1; DAIDZIN; ESTRADIOL; GENISTIN; KALLIKREIN; KALLIKREIN 6; MESSENGER RNA; PHYTOESTROGEN; PROGESTERONE RECEPTOR; PROTEIN PS2; SAPONIN; SOYSELECT SSE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN ACTIVITY; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; HERBAL MEDICINE; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOSIS INHIBITION; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SHORT COURSE THERAPY; SOYBEAN; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UTERUS WEIGHT;

ANIMALS; BODY WEIGHT; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OVARIECTOMY; PHYTOESTROGENS; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOYBEAN PROTEINS; UTERUS;

EID: 33745590422     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi338     Document Type: Article

References (35)

1. Ferlay,J., Bray,F., Pisani,P. and Parkin,D.M. (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. version 2.0, IARC, Lyon.
2. Messina,M. and Barnes,S. (1991) The role of soy products in reducing risk of cancer. J. Natl Cancer Inst., 83, 541-546.
3. Lee,M.M., Lin,S.S., Wrensch,M.R., Adler,S.R. and Eisenberg,D. (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J. Natl Cancer Inst., 92, 42-47.
4. Morris,K.T., Johnson,N., Homer,L. and Walts,D. (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am. J. Surg., 179, 407-411.
5. Newton,K.M., Buist,D.S., Keenan,N.L., Anderson,L.A. and LaCroix,A.Z. (2002) Use of alternative therapies for menopause symptoms: Results of a population-based survey. Obstet. Gynecol., 100, 18-25.
6. Messina,M.J. and Loprinzi,C.L. (2001) Soy for breast cancer survivors: A critical review of the literature. J. Nutr., 131 (Suppl 11), 3095S-108S, Review.
7. Gallo,D., Zannoni,G.F., Apollonio,P., Martinelli,E., Ferlini,C., Passetti,G., Riva,A., Morazzoni,P., Bombardelli,E. and Scambia,G. (2005) Characterization of the pharmacological profile of a standardized soy extract in the ovariectomized rat model of menopause: Effects on bone, uterus, and lipid profile. Menopause, 12, 589-600.
8. Gallo,D., Zannoni,G.F., Martinelli,E., Ferlini,C., Fabrizi,M., Riva,A., Morazzoni,P., Bombardelli,E. and Scambia,G. (2006) Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland. Menopause, 13, 72-79.
9. Morton,M.S., Arisaka,O., Miyake,N., Morgan,L.D. and Evans,B.A. (2002) Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J. Nutr., 132, 3168-3171.
10. Scambia,G., Mango,D., Signorile,P.G., Anselmi Angeli,R.A., Palena,C., Gallo,D., Bombardelli,E., Morazzoni,P., Riva,A. and Mancuso,S. (2000) Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause, 7, 105-111.
11. Corbett,T., Valeriote,F., LoRusso,P., Polin,L., Panchapor,C., Pugh,S., White,K., Knight,J., Demchik,L., Jones,J., Jones,L. and Lisow,L. (1997) In vivo methods for screening and preclinical testing. In Teicher,BA. (ed) Anticancer Drug Development Guide. Humana Press, Totowa, NJ, pp. 75-99.
12. Passaniti,A., Taylor,R.M., Pili,R., Guo,Y., Long,P.V., Haney,J.A., Pauly,R.R., Grant,D.S. and Martin,G.R. (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest., 67, 519-528.
13. Wang,T.T., Sathyamoorthy,N. and Phang,J.M. (1996) Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17, 271-275.
14. Hsieh,C.Y., Santell,R.C., Haslam,S.Z. and Helferich,W.G. (1998) Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res., 58, 3833-3838.
15. Miodini,P., Fioravanti,L., Di Fronzo,G. and Cappelletti,V. (1999) The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br J Cancer., 80, 1150-1155.
16. Maggiolini,M., Bonofiglio,D., Marsico,S., Panno,M.L., Cenni,B., Picard,D. and Ando,S. (2001) Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol, 60, 595-602.
17. Ju,Y.H., Allred,C.D., Allred,K.F., Karko,K.L., Doerge,D.R. and Helferich,W.G. (2001) Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr., 131, 2957-2962.
18. Allred,C.D., Allred,K.F., Ju,Y.H., Virant,S.M. and Helferich,W.G. (2001) Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res., 61, 5045-5050.
19. Allred,C.D., Ju,Y.H., Allred,K.F., Chang,J. and Helferich,W.G. (2001) Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis, 22, 1667-1673.
20. Allred,C.D., Allred,K.F., Ju,Y.H., Goeppinger,T.S., Doerge,D.R. and Helferich,W.G. (2004) Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis, 25, 1649-1657.
21. Shao,Z.M., Wu,J., Shen,Z.Z. and Barsky,S.H. (1998) Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res., 58, 4851-4857.
22. Jeffery,E. (2005) Component interactions for efficacy of functional foods. J. Nutr., 135, 1223-1225.
23. Brown,A.M., Jeltsch,J.M., Roberts,M. and Chambon,P. (1984) Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl Acad. Sci. USA, 81, 6344-6348.
24. Cho,H., Aronica,S.M. and Katzenellenbogen,B.S. (1994) Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: A comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-I, and serum factors. Endocrinology, 134, 658-664.
25. Altucci,L., Addeo,R., Cicatiello,L., Dauvois,S., Parker,M.G., Truss,M., Beato,M., Sica,V., Bresciani,F. and Weisz,A. (1996) 17β-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene, 12, 2315-2324.
26. Li,Y. and Sarkar,F.H. (2002) Gene expression profiles of genistein-treated PC3 prostate cancer cells. J. Nutr., 132, 3623-3631.
27. Ghosh,M.G., Thompson,D.A. and Weigel,R.J. (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res., 60, 6367-6375.
28. Borgono,C.A. and Diamandis,E.P. (2004) The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer, 4, 876-890, Review.
29. Esemuede,N., Lee,T., Pierre-Paul,D., Sumpio,B.E and Gahtan,V. (2004) The role of thrombospondin-1 in human disease. J. Surg. Res., 122, 135-142. Review.
30. Derynck,R., Akhurst,R.J. and Balmain,A. (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat.Genet., 29, 117-129. Review.
31. Muraoka-Cook,R.S., Dumont,N. and Arteaga,C.L. (2005) Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression. Clin. Cancer Res., 11, 937s-943s. Review.
32. Gallo,D., Giacomelli,S., Cantelmo,F. et al. (2001) Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy. Breast Cancer Res. Treat., 69, 153-164.
33. Fotsis,T., Pepper,M., Adlercreutz,H., Fleischmann,G.,Hase,T.,Montesano,R. and Schweigerer,L. (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl Acad. Sci. USA, 90, 2690-2694.
34. Upmalis,D.H., Lobo,R., Bradley,L., Warren,M., Cone,F.L. and Lamia,C.A. (2000) Vasomotor symptom relief by soy isoflavone extract tablets inpostmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause, 7, 236-242.
35. Kritz-Silverstein,D., Von Muhlen,D., Barrett-Connor,E. and Bressel,M.A. (2003) Isoflavones and cognitive function in older women: The SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause, 10, 196-202.